Drug Information
| Drug General Information | Top | |||
|---|---|---|---|---|
| Drug ID |
D05TWV
|
|||
| Former ID |
DNC014485
|
|||
| Drug Name |
(+/-)-threo-N-Methyl-30-methylmethylphenidate
|
|||
| Synonyms |
CHEMBL19686; BDBM50291690; (R)-((R)-1-Methyl-piperidin-2-yl)-m-tolyl-acetic acid methyl ester
Click to Show/Hide
|
|||
| Drug Type |
Small molecular drug
|
|||
| Indication | Discovery agent [ICD-11: N.A.] | Investigative | [1] | |
| Structure |
 |
Download2D MOL |
||
| Formula |
C16H23NO2
|
|||
| Canonical SMILES |
CC1=CC(=CC=C1)C(C2CCCCN2C)C(=O)OC
|
|||
| InChI |
1S/C16H23NO2/c1-12-7-6-8-13(11-12)15(16(18)19-3)14-9-4-5-10-17(14)2/h6-8,11,14-15H,4-5,9-10H2,1-3H3/t14-,15-/m1/s1
|
|||
| InChIKey |
NEQATLAJGKQCLO-HUUCEWRRSA-N
|
|||
| PubChem Compound ID | ||||
| Target and Pathway | Top | |||
|---|---|---|---|---|
| Target(s) | Dopamine transporter (DAT) | Target Info | Inhibitor | [1] |
| KEGG Pathway | Dopaminergic synapse | |||
| Parkinson's disease | ||||
| Cocaine addiction | ||||
| Amphetamine addiction | ||||
| Alcoholism | ||||
| Panther Pathway | Adrenaline and noradrenaline biosynthesis | |||
| Parkinson disease | ||||
| Dopamine receptor mediated signaling pathway | ||||
| Pathway Interaction Database | Alpha-synuclein signaling | |||
| Reactome | Na+/Cl- dependent neurotransmitter transporters | |||
| WikiPathways | Monoamine Transport | |||
| NRF2 pathway | ||||
| Dopaminergic Neurogenesis | ||||
| Parkinsons Disease Pathway | ||||
| Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds | ||||
| Neurotransmitter Clearance In The Synaptic Cleft | ||||
| References | Top | |||
|---|---|---|---|---|
| REF 1 | Quantitative structure-activity relationship studies of threo-methylphenidate analogs. Bioorg Med Chem. 2010 Oct 15;18(20):7221-38. | |||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.